CREM
Basic information
Region (hg38): 10:35126791-35212958
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CREM gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 11 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 9 | 1 | 3 |
Variants in CREM
This is a list of pathogenic ClinVar variants found in the CREM region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-35148438-T-C | not specified | Uncertain significance (May 02, 2024) | ||
10-35178983-A-T | not specified | Uncertain significance (Aug 13, 2021) | ||
10-35179145-A-G | not specified | Uncertain significance (Dec 28, 2022) | ||
10-35179179-G-A | Benign (Dec 31, 2019) | |||
10-35179247-G-A | not specified | Uncertain significance (Jan 03, 2024) | ||
10-35179265-C-A | not specified | Uncertain significance (Jul 19, 2023) | ||
10-35179265-C-T | not specified | Uncertain significance (Oct 22, 2021) | ||
10-35188293-C-T | not specified | Uncertain significance (Mar 16, 2022) | ||
10-35188305-G-A | not specified | Uncertain significance (Feb 28, 2024) | ||
10-35206928-G-A | not specified | Uncertain significance (Jun 02, 2023) | ||
10-35206973-C-T | Likely benign (Mar 29, 2018) | |||
10-35206978-G-A | not specified | Uncertain significance (Jul 26, 2024) | ||
10-35207028-A-G | Benign (Jun 29, 2018) | |||
10-35211742-A-G | not specified | Uncertain significance (Feb 06, 2023) | ||
10-35211745-A-G | Benign (Jul 06, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CREM | protein_coding | protein_coding | ENST00000345491 | 7 | 86168 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.509 | 0.491 | 125710 | 0 | 18 | 125728 | 0.0000716 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.462 | 145 | 162 | 0.898 | 0.00000801 | 1922 |
Missense in Polyphen | 41 | 58.474 | 0.70117 | 679 | ||
Synonymous | -0.0895 | 55 | 54.2 | 1.02 | 0.00000268 | 611 |
Loss of Function | 3.23 | 4 | 19.3 | 0.207 | 0.00000124 | 191 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000546 | 0.0000544 |
Finnish | 0.0000925 | 0.0000924 |
European (Non-Finnish) | 0.0000555 | 0.0000527 |
Middle Eastern | 0.0000546 | 0.0000544 |
South Asian | 0.000269 | 0.000261 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional regulator that binds the cAMP response element (CRE), a sequence present in many viral and cellular promoters. Isoforms are either transcriptional activators or repressors. Plays a role in spermatogenesis and is involved in spermatid maturation (PubMed:10373550). {ECO:0000269|PubMed:10373550}.;
- Pathway
- HTLV-I infection - Homo sapiens (human);Adrenergic signaling in cardiomyocytes - Homo sapiens (human);Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways;repression of pain sensation by the transcriptional regulator dream;regulation of spermatogenesis by crem;Calcineurin-regulated NFAT-dependent transcription in lymphocytes;Calcium signaling in the CD4+ TCR pathway
(Consensus)
Recessive Scores
- pRec
- 0.256
Intolerance Scores
- loftool
- 0.760
- rvis_EVS
- -0.27
- rvis_percentile_EVS
- 34.6
Haploinsufficiency Scores
- pHI
- 0.800
- hipred
- Y
- hipred_score
- 0.825
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.981
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Crem
- Phenotype
- endocrine/exocrine gland phenotype; cellular phenotype; muscle phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; liver/biliary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;glucose metabolic process;regulation of transcription, DNA-templated;fatty acid metabolic process;glycosphingolipid metabolic process;signal transduction;multicellular organism development;spermatogenesis;cell differentiation;regulation of circadian rhythm;positive regulation of transcription by RNA polymerase II;retinoic acid receptor signaling pathway;rhythmic process
- Cellular component
- nucleus;transcription factor complex;cytoplasm
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA binding;protein binding;cAMP response element binding protein binding